Product Images Xembify
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 18 images provide visual information about the product associated with Xembify NDC 13533-810 by Grifols Usa, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Xembify is a solution for subcutaneous administration used as an immune globulin. The recommended storage temperature is 2-6% (36-45°F) and can be kept for up to 6 months below 25°C (77°F), after which it should be discarded. The solution comes in a single-use vial and should not be used if it shows any signs of tampering. The package insert should be referred to for dosage and administration information. Each mililiter (L) contains approximately 200 mg of roten, of which less than 8% is gamma globulin, 15 mg of alycine, and 25 mg of polysorbate 8. Grifols Therapeutics LLC is the manufacturer of Xembify, and their contact details are provided on the packaging. The given text does not contain any further specific details regarding the use and benefits of Xembify.*
Xembify is a solution for subcutaneous administration containing immune globulin with other solutions. It is available in a single use vial and must be used as per the instructions on the package insert for dosage and administration and compatibility with other products. It can be stored at 2-8°C (36-46°F) and at temperatures not exceeding 25°C (77°F) for up to 6 months before the expiry date, after which it must be used immediately. The product is manufactured by Grifols Therapeutics LLO and is intended for human use only with a US License No. 1871.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.